Compound name
              Crizotinib
          Alt Name
          Xalkori
           Crizonix
              Compound Image
              Crizotinib.png
          SMILES
              CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N
          Brutto
              C21H22Cl2FN5O
          InChI
              InChI=1S/C21H22Cl2FN5O/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15/h2-3,8-12,15,26H,4-7H2,1H3,(H2,25,27)/t12-/m1/s1
          InChI Key
              KTEIFNKAUNYNJU-GFCCVEGCSA-N
          Approval Jurisdiction
              2011 FDA
          Approved for clinical use
              NSCLC With Alkmutation
          CAS
              877399-52-5
          PubChem CID
              11626560
          Action
              ALK, MET
          Approved Drug List
              1
          Commercial Vendor
              Pfizer
          Reference
              
          Reference 2
              
          
